InsiderTrades

Form 4 for OMDA Omada Health, Inc.

Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-05 · accession 0001610717-25-000184 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-06-09 2025-06-05 OMDA FETTER TREVOR Dir A - Grant $0.00 +9,736 9,736 New $0
DI 2025-06-09 2025-06-09 OMDA FETTER TREVOR Dir C - Cnv Deriv — +111.2K 111.2K New —
DMI 2025-06-09 2025-06-09 OMDA FETTER TREVOR Dir C - Cnv Deriv — -111.2K 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-05 A A 9,736 $0.00 9,736 D See footnote — — (F1) Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the first anniversary of June 5, 2025. (F3) Shares held by a limited liability company of which the Reporting Person is the sole member.
2 Common Common Stock 2025-06-09 C A 111,200 — 111,200 I — — (F2) Each share of Series D-1 Preferred Stock and Series E Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date.
3 Derivative Series E Preferred Stock 2025-06-09 C D 55,600 — 0 I See footnote — · — to — 55,600 Common Stock (F2) Each share of Series D-1 Preferred Stock and Series E Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date. (F3) Shares held by a limited liability company of which the Reporting Person is the sole member.
4 Derivative Series D-1 Preferred Stock 2025-06-09 C D 55,600 — 0 I See footnote — · — to — 55,600 Common Stock (F2) Each share of Series D-1 Preferred Stock and Series E Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date. (F3) Shares held by a limited liability company of which the Reporting Person is the sole member.